|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02138 EC HEALTHCARE
Nominal 
0.690 -0.020 (-2.817%) | 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Turnover | 2,062,897 | -2.754% | 2,121,312 | 1,893,186 | 1,443,680 | 797,367 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (136) | 36.000% | (100) | (3,234) | -- | -- | |
| Share of Results of Asso. & JCEs | 1,748 | -58.977% | 4,261 | 7,982 | 1,402 | 496 | |
| Profit / (Loss) before Taxation | 56,642 | 60.541% | 35,282 | 124,394 | 231,718 | 60,872 | |
| Taxation | (16,341) | 17.977% | (13,851) | (19,187) | (35,653) | (7,568) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (26,204) | 77.294% | (14,780) | (25,161) | (35,857) | (9,376) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 14,097 | 111.953% | 6,651 | 80,046 | 160,208 | 43,928 | |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Net Finance Costs / (Income) | 41,754 | 13.555% | 36,770 | 31,287 | 17,271 | 8,438 |
| Depreciation & Amortisation | 291,181 | -4.447% | 304,731 | 286,061 | 188,200 | 125,644 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| EPS (cts) | 1.200 | 100.000% | 0.600 | 6.800 | 14.200 | 4.400 |
| DPS (cts) | 1.000 | -- | 0.500 | 5.800 | 10.200 | 3.000 |
| Dividend Payout Ratio (%) | 83.333% | -- | 83.333% | 85.294% | 71.831% | 68.182% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.697 | -- | 1.586 | 1.648 | 1.790 | 1.062 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 14,097 |
| %Change | 111.953% |
| EPS / (LPS) | HKD 0.012 |
| NBV Per Share ($) | HKD 1.697 |